For: | Fujimoto Y, Kaji K, Nishimura N, Enomoto M, Murata K, Takeda S, Takaya H, Kawaratani H, Moriya K, Namisaki T, Akahane T, Yoshiji H. Dual therapy with zinc acetate and rifaximin prevents from ethanol-induced liver fibrosis by maintaining intestinal barrier integrity. World J Gastroenterol 2021; 27(48): 8323-8342 [PMID: 35068872 DOI: 10.3748/wjg.v27.i48.8323] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v27/i48/8323.htm |
Number | Citing Articles |
1 |
Akihiko Shibamoto, Kosuke Kaji, Norihisa Nishimura, Takahiro Kubo, Satoshi Iwai, Fumimasa Tomooka, Junya Suzuki, Yuki Tsuji, Yukihisa Fujinaga, Hideto Kawaratani, Tadashi Namisaki, Takemi Akahane, Hitoshi Yoshiji. Vitamin D deficiency exacerbates alcohol-related liver injury via gut barrier disruption and hepatic overload of endotoxin. The Journal of Nutritional Biochemistry 2023; 122: 109450 doi: 10.1016/j.jnutbio.2023.109450
|
2 |
Fatma Betül Yoladi, Saziye Sezin Palabiyik-Yucelik, Elham Bahador Zirh, Zekai Halici, Terken Baydar. Effects of idebenone and coenzyme Q10 on NLRP3/caspase-1/IL-1β pathway regulation on ethanol-induced hepatotoxicity in rats. Drug and Chemical Toxicology 2024; : 1 doi: 10.1080/01480545.2024.2351191
|
3 |
Nima Zafari, Mahla Velayati, Mostafa Fahim, Mina Maftouh, Ghazaleh Pourali, Majid Khazaei, Mohammadreza Nassiri, Seyed Mahdi Hassanian, Majid Ghayour-Mobarhan, Gordon A. Ferns, Mohammad Ali Kiani, Amir Avan. Role of gut bacterial and non-bacterial microbiota in alcohol-associated liver disease: Molecular mechanisms, biomarkers, and therapeutic prospective. Life Sciences 2022; 305: 120760 doi: 10.1016/j.lfs.2022.120760
|
4 |
Shasha Hou, Dan Wang, Xiaxia Yuan, Xiaohuan Yuan, Qi Yuan. Identification of biomarkers co-associated with M1 macrophages, ferroptosis and cuproptosis in alcoholic hepatitis by bioinformatics and experimental verification. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1146693
|
5 |
Hiroki Nishikawa, Soo Ki Kim, Akira Asai. Body Composition in Chronic Liver Disease. International Journal of Molecular Sciences 2024; 25(2): 964 doi: 10.3390/ijms25020964
|
6 |
Tomoko Tadokoro, Asahiro Morishita, Takashi Himoto, Tsutomu Masaki. Nutritional Support for Alcoholic Liver Disease. Nutrients 2023; 15(6): 1360 doi: 10.3390/nu15061360
|
7 |
Hongtao Ou, Qingyan Chen, Zhongjing Lin, Yang Yang, Peixin Wang, Natthida Sriboonvorakul, Shaoling Lin. RNA-seq Analysis Reveals Potential Synergic Effects of Acetate and Cold Exposure on Interscapular Brown Adipose Tissue in Mice. Biology 2023; 12(10): 1285 doi: 10.3390/biology12101285
|
8 |
Takao Miwa, Tatsunori Hanai, Kenji Imai, Koji Takai, Makoto Shiraki, Hideki Hayashi, Shogo Shimizu, Yoichi Nishigaki, Eiichi Tomita, Masahito Shimizu. Effects of Rifaximin on Circulating Albumin Structures and Serum Ammonia Levels in Patients with Liver Cirrhosis: A Preliminary Study. Journal of Clinical Medicine 2022; 11(24): 7318 doi: 10.3390/jcm11247318
|
9 |
Michael Roth, Bo Han, Chong Teck S’ng, Ba Xuan Hoang, Christopher Lambers. Zinc Iodide Dimethyl Sulfoxide Reduces Collagen Deposition by Increased Matrix Metalloproteinase-2 Expression and Activity in Lung Fibroblasts. Biomedicines 2024; 12(6): 1257 doi: 10.3390/biomedicines12061257
|
10 |
Aritoshi Koizumi, Kosuke Kaji, Norihisa Nishimura, Shohei Asada, Takuya Matsuda, Misako Tanaka, Nobuyuki Yorioka, Yuki Tsuji, Koh Kitagawa, Shinya Sato, Tadashi Namisaki, Takemi Akahane, Hitoshi Yoshiji. Effects of elafibranor on liver fibrosis and gut barrier function in a mouse model of alcohol-associated liver disease. World Journal of Gastroenterology 2024; 30(28): 3428-3446 doi: 10.3748/wjg.v30.i28.3428
Abstract(71) |
Core Tip(93) |
Full Article(HTML)(642)
|
Full Article with Cover (PDF)-27476K(17)
|
Audio-2339K(4)
|
Peer-Review Report-254K(10)
|
Answering Reviewers-189K(9)
|
Supplementary Material-514K(12)
|
Full Article (PDF)-27135K(60)
|
Full Article (XML)-172K(10)
|
Times Cited (0)
|
Total Visits (1471)
|
Open
|
11 |
Masahide Enomoto, Kosuke Kaji, Norihisa Nishimura, Yuki Fujimoto, Koji Murata, Soichi Takeda, Yuki Tsuji, Yukihisa Fujinaga, Hiroaki Takaya, Hideto Kawaratani, Tadashi Namisaki, Takemi Akahane, Hitoshi Yoshiji. Rifaximin and lubiprostone mitigate liver fibrosis development by repairing gut barrier function in diet–induced rat steatohepatitis. Digestive and Liver Disease 2022; 54(10): 1392 doi: 10.1016/j.dld.2022.04.012
|
12 |
Yanping Fan, Meilan Xue, Tianhu Shan, Yixian Bai, Huaqi Zhang, Man Liu, Peng Wang, Xi Liang, Hui Liang. Niacin alleviates extracellular matrix deposition in ethanol + CCl4-induced liver fibrosis through the HSP90/JAK1/STAT3 axis. Food Bioscience 2024; 57: 103454 doi: 10.1016/j.fbio.2023.103454
|
13 |
Matheus Truccolo Michalczuk, Larisse Longo, Melina Belén Keingeski, Bruno de Souza Basso, Gabriel Tayguara Silveira Guerreiro, Jessica T Ferrari, José Eduardo Vargas, Cláudia P Oliveira, Carolina Uribe-Cruz, Carlos Thadeu Schmidt Cerski, Eduardo Filippi-Chiela, Mário Reis Álvares-da-Silva. Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease. World Journal of Hepatology 2024; 16(1): 75-90 doi: 10.4254/wjh.v16.i1.75
Abstract(223) |
Core Tip(219) |
Full Article(HTML)(1211)
|
Full Article with Cover (PDF)-16750K(41)
|
Full Article (Word)-3197K(17)
|
Audio-376K(3)
|
Peer-Review Report-182K(27)
|
Answering Reviewers-60K(38)
|
Supplementary Material-355K(33)
|
Full Article (PDF)-6006K(72)
|
Full Article (XML)-200K(28)
|
Times Cited (0)
|
Total Visits (3515)
|
Open
|